EFFECTIVENESS OF INHALED CORTICOSTEROIDS (ICS) COMBINATION THERAPY; THE ADDITION OF QVAR^<TM> TO FLUTIDE^<TM>
-
- Kaneko Norihiro
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Okuni Yoshihiro
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Tanabe Yuko
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Hasegawa Keiko
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Inoue Keiichi
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Yasui Daisaku
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Ayabe Eriko
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Satou Chieko
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Mitsuishi Youichirou
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Nakashita Tamao
- Department of Pulmonary Medicine, Kameda Medical Center
-
- Motojima Shinji
- Department of Pulmonary Medicine, Kameda Medical Center
Bibliographic Information
- Other Title
-
- フルタイド^<TM>とキュバール^<TM>の吸入ステロイド併用療法の有用性
- フルタイドとキュバールの吸入ステロイド併用療法の有用性
- フルタイド ト キュバール ノ キュウニュウ ステロイド ヘイヨウ リョウホウ ノ ユウヨウセイ
Search this article
Description
Purpose: We recently reported treatment of asthmatic patients with a combination of FP-DPI 800μg/day and BDP-HFA 400μg/day. This regimen induced significant improvement in subjective symptoms and pulmonary function tests. This led us to study the additive effect of BDP-HFA 400μg/day for seven unstable severe persistent bronchial asthma patients. Results: PEF improved, daily (circadian) variation was minimized and FVC and FEV_<1.0> testing showed slight improvement. V25/height also revealed significant improvement. The more peripheral the airways are, the greater improvement was observed. The annual emergency admission rate of 4.6 times per patient decreased to 2.1 times after the addition of BDP-HFA 400μg/day. All the three cases dependent on oral steroid medication could be removed from the drug and 6 out of 7 cases were able to lower the dose of anti-asthmatic drugs. Conclusions: The effectiveness of inhaled corticosteroids (ICS) differs based on the site reached in the bronchi and depending on the inhalation devices used. Addition of a second ICS has the potential to further alleviate symptoms of unstable asthmatics on conventional therapy with ICS and other drugs.
Journal
-
- Japanese Journal of Allergology
-
Japanese Journal of Allergology 57 (6), 706-712, 2008
Japanese Society of Allergology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204990867712
-
- NII Article ID
- 110006825240
-
- NII Book ID
- AN00012583
-
- ISSN
- 13477935
- 00214884
-
- NDL BIB ID
- 9577513
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- CiNii Articles
-
- Abstract License Flag
- Disallowed